Demonstration of myocardial reperfusion injury in humans: Results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction

Journal of the American College of Cardiology

Volumn 18, Issue 4, 1991, Pages 911-918

  Forman, Mervyn B ^e   Perry, James M ^e   Wilson, B Hadley ^a,b   Verani, Mario S ^c   Kaplan, Peter R ^e   Shawl, Fayaz A ^d   Friesinger, Gottlieb C ^e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sanger Clinic   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d WASHINGTON ADVENTIST HOSPITAL   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOSOL; BLOOD SUBSTITUTE; FLUOROCARBON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; CLINICAL TRIAL; COMPARATIVE STUDY; EMERGENCY; HEART; HEART CATHETERIZATION; HEART VENTRICLE FUNCTION; MULTICENTER STUDY; PHYSIOLOGY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SCINTISCANNING; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD SUBSTITUTES; COMPARATIVE STUDY; EMERGENCIES; FEMALE; FLUOROCARBONS; HEART; HEART CATHETERIZATION; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PILOT PROJECTS; VENTRICULAR FUNCTION;

EID: 0025925095     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(91)90746-V     Document Type: Article

References (38)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
2. Randomized trial of intravenous streptokinase oral aspirin both or neither among 17187 cases of suspected acute myocardial infarction ISIS-2
3. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombosis (ASSET)
4. Effect of intravenous APSAC on mortality after acute myocardial infarction preliminary report of a placebo-controlled trial
5. The Western Washington intravenous streptokinase in acute myocardial infarction randomized trial
6. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction
7. Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 hours after onset of myocardial infarction
8. Intravenous type plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction
9. Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function
10. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase
11. Ventricular function and infarct size: the Western Washington intravenous streptokinase in myocardial infarction trial
12. Myocardial reperfusion: a double-edged sword?
13. Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications
14. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion
15. Beneficial long-term effect of intracoronary perfluorochemical on intarct size and ventricular function in a canine reperfusion model
16. A randomized, double-blind, controlled pilot trial of combined early intravenous captopril and t-PA therapy in acute myocardial infarction (abstr)
17. Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction
18. A randomized, double-blind trial of recombinant human superoxide dismutase (SOD) in patients undergoing PTCA for acute MI (abstr)
19. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from thrombolysis in myocardial infarction (TIMI phase I trial)
20. Determinants of left ventricular aneurysm formation after anterior myocardial infarction: a clinical and angiographic study
21. The use of single plane angiocardiograms for calculation of left ventricular volume in man
22. Advantages and applications of the centerline method of characterizing regional ventricular function
23. 201T1 single-photon emission computed tomography during acute myocardial infarction in humans: comparison with enzymatic estimates
24. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon
25. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury
26. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury
27. Deleterious effects of oxygen radicals in ischemia/reperfusion
28. Oxygen radicals mediate endothelial damage by complement-stimulated granulocytes
29. Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase
30. In hospital cases of death in patients admitted to the GISSI Study
31. Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction
32. Effect of perfluorochemical Fluosol-DA on myocardial infarct healing in the rabbit
33. Oxygen transport in vivo by means of perfluorochemical preparations
34. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol
35. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion
36. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals: role of neutrophil activation
37. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion
38. The stunned myocardium: prolonged, postischemic ventricular dysfunction